Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Атмосфера. Новости кардиологии
2021 / N 1

Витамин D и хроническая сердечная недостаточность: взаимосвязь и точки пересечения
Э.К. Яралиева, И.А. Скрипникова, В.Н. Шишкова, О.М. Драпкина


References

1. Fomin IV. Chronic heart failure in the Russian Federation: what we know today and what we should do. Russian Journal of Cardiology 2016;8(136):7-13 (In Russian).
2. Dedov II, Shestakova MV, Vikulova OK. Epidemiology of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to data of Federal register of diabetes mellitus. Diabetes Mellitus 2017;20(1):13-41 (In Russian).
3. Badin YuV, Fomin IV, Belenkov YuN, Mareyev VYu, Ageyev FT, Polyakov DS, Artemyeva EG, Galyavich AS, Ionova TS, Kamalov GM, Kechedzhiyeva SG, Koziolova NA, Malenkova VYu, Malchikova SV, Smirnova EA, Tarlovskaya EI, Shcherbinina EV, Valikulova FYu, Vaysberg AR, Yakushin SS. EPOCHA-AH 1998–2017: dynamics of prevalence, awareness of arterial hypertension, treatment coverage, and effective control of blood pressure in the European part of the Russian Federation. Kardiologiia 2019;59(1S):34-42 (In Russian).
4. Fleck A. Latitude and ischaemic heart disease. The Lancet 1989 Mar;333(8638):613.
5. Enquselassie F, Dobson AJ, Alexander HM, Steele PL. Seasons, temperature and coronary disease. International Journal of Epidemiology 1993 Aug;22(4):632-6.
6. Douglas AS, Allan TM, Rawles JM. Composition of seasonality of disease. Scottish Medical Journal 1991 Jun;36(3):76-82.
7. Saponaro F, Saba A, Frascarelli S, Frontera C, Clerico A, Scalese M, Sessa MR, Cetani F, Borsari S, Pardi E, Marvelli A, Marcocci C, Passino C, Zucchi R. Vitamin D measurement and effect on outcome in a cohort of patients with heart failure. Endocrine Connections 2018 Sep;7(9):957-64.
8. D’Amore C, Marsico F, Parente A, Paolillo S, De Martino F, Gargiulo P, Ferrazzano F, De Roberto AM, La Mura L, Marciano C, Dellegrottaglie S, Trimarco B, Perrone Filardi P. Vitamin D deficiency and clinical outcome in patients with chronic heart failure: a review. Nutrition, Metabolism & Cardiovascular Diseases 2017 Oct;27(10):837-49.
9. Holick MF. Vitamin D deficiency. The New England Journal of Medicine 2007 Jul;357(3):266-81.
10. Wang TJ. Vitamin D and cardiovascular disease. Annual Review of Medicine 2016;67:261-72.
11. Krul-Poel YH, Ter Wee MM, Lips P, Simsek S. Management of endocrine disease: the effect of vitamin D supplementation on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. European Journal of Endocrinology 2017 Jan;176(1):R1-14.
12. Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. The Biochemical Journal 2012 Jan;441(1):61-76.
13. Hewison M. An update on vitamin D and human immunity. Clinical Endocrinology 2012 Mar;76(3):315-25.
14. Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, Jaccard N, Knoll E, Stern N. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005 Apr;111(13):1666-71.
15. Roffe-Vazquez DN, Huerta-Delgado AS, Castillo EC, Villarreal-Calderón JR, Gonzalez-Gil AM, Enriquez C, Garcia-Rivas G, Elizondo-Montemayor L. Correlation of vitamin D with inflammatory cytokines, atherosclerotic parameters, and lifestyle factors in the setting of heart failure: a 12-month follow-up study. International Journal of Molecular Science 2019 Nov;20(22):5811.
16. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. The Journal of Clinical Investigation 2002 Jul;110(2):229-38.
17. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, März W. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clinica Chimica Acta 2010 Sep;411(17-18):1354-60.
18. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension (Dallas, Tex.: 1979) 2010 May;55(5):1283-8.
19. Zhang W, Chen L, Zhang L, Xiao M, Ding J, Goltzman D, Miao D. Administration of exogenous 1,25(OH)2D3 normalizes overactivation of the central renin-angiotensin system in 1alpha(OH)ase knockout mice. Neuroscience Letters 2015 Feb;588:184-9.
20. Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. American Journal of Physiology. Endocrinology and Metabolism 2005 Jan;288(1):E125-32.
21. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH)2D3 dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney International 2008 Jul;74(2):170-9.
22. Frostegård J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999 Jul;145(1):33-43.
23. Bhalla AK, Amento EP, Krane SM. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cellular Immunology 1986 Apr;98(2):311-22.
24. Dibaba DT. Effect of vitamin D supplementation on serum lipid profiles: a systematic review and meta-analysis. Nutrition Reviews 2019 Dec;77(12):890-902.
25. Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. The Journal of Steroid Biochemistry and Molecular Biology 2007 Mar;103(3-5):416-9.
26. Wu J, Garami M, Cheng T, Gardner DG. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. The Journal of Clinical Investigation 1996 Apr;97(7):1577-88.
27. Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, Rigor DL, Stillman I, Tamez H, Kroeger PE, Wu-Wong RR, Karumanchi SA, Thadhani R, Kang PM. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proceedings of the National Academy of Sciences of the USA 2007 Oct;104(43):16810-5.
28. Meems LM, Cannon MV, Mahmud H, Voors AA, van Gilst WH, Sillje HH, Rigor DL, Stillman I, Tamez H, Kroeger PE, Wu-Wong RR, Karumanchi SA, Thadhani R, Kang PM. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. The Journal of Steroid Biochemistry and Molecular Biology 2012 Nov;132(3-5):282-9.
29. Green JJ, Robinson DA, Wilson GE, Simpson RU, Westfall MV. Calcitriol modulation of cardiac contractile performance via protein kinase C. Journal of Molecular and Cellular Cardiology 2006 Aug;41(2):350-9.
30. Weishaar RE, Kim SN, Saunders DE, Simpson RU. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. The American Journal of Physiology. Endocrinology and Metabolism 1990 Jan;258(1 Pt 1):E134-42.
31. Schwetz V, Scharnagl H, Trummer C, Stojakovic T, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, Aberer F, Lerchbaum E, Obermayer-Pietsch B, Pieber TR, März W, Tomaschitz A, Pilz S. Vitamin D supplementation and lipoprotein metabolism: a randomized controlled trial. Journal of Clinical Lipidology 2018 May-Jun;12(3):588-96.e4.
32. Brunvand L, Hågå P, Tangsrud SE, Haug E. Congestive heart failure caused by vitamin D deficiency? Acta Paediatrica (Oslo, Norway: 1992) 1995 Jan;84(1):106-8.
33. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, McMahon DJ. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. The American Journal of Medicine 1997 Sep;103(3):197-207.
34. Lutsey PL, Michos ED, Misialek JR, Pankow JS, Loehr L, Selvin E, Reis JP, Gross M, Eckfeldt JH, Folsom AR. Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure: the ARIC (Atherosclerosis Risk In Communities) study. JACC. Heart Failure 2015 May;3(5):347-56.
35. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappé DL, Muhlestein JB; Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. The American Journal of Cardiology 2010 Oct;106(7):963-8.
36. Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, Shlipak MG, Jenny NS, Siscovick DS. Vitamin D, parathyroid hormone, and cardio-vascular events among older adults. American Journal of Cardiology 2011 Sep;58(14):1433-41.
37. di Giuseppe R, Buijsse B, Hirche F, Wirth J, Arregui M, Westphal S, Isermann B, Hense HW, Dierkes J, Boeing H, Stangl G, Weikert C. Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: a prospective, case-cohort study. The Journal of Clinical Endocrinology & Metabolism 2014 Mar;99(3):947-55.
38. Aparicio-Ugarriza R, Salguero D, Mohammed YN, Ferri-Guerra J, Baskaran DJ, Mirabbasi SA, Rodriguez A, Ruiz JG. Is vitamin D deficiency related to a higher risk of hospitalization and mortality in veterans with heart failure? Maturitas 2020 Feb;132:30-4.
39. Liu LC, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, Silljé HHW, van Gilst WH, Jaarsma T, de Boer RA. Vitamin D status and outcomes in heart failure patients. European Journal of Heart Failure 2011 Jun;13(6):619-25.
40. Gotsman I, Shauer A, Zwas DR, Hellman Y, Keren A, Lotan C, Admon D. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. European Journal of Heart Failure 2012 Apr;14(4):357-66.
41. Gruson D, Ferracin B, Ahn SA, Zierold C, Blocki F, Hawkins DM, Bonelli F, Rousseau MF. 1,25-Dihydroxyvitamin D to PTH(1-84) ratios strongly predict cardiovascular death in heart failure. PloS One 2015 Aug;10(8):e0135427.
42. Jiang WL, Gu HB, Zhang YF, Xia QQ, Qi J, Chen JC. Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clinical Cardiology 2016 Jan;39(1):56-61.
43. Wang T, Liu Z, Fu J, Min Z. Meta-analysis of vitamin D supplementation in the treatment of chronic heart failure. Scandinavian Cardiovascular Journal 2019 Jun;53(3):110-6.
44. Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, D’Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE; VITAL Research Group. Vitamin D supplements and prevention of cancer and cardiovascular disease. The New England Journal of Medicine 2019 Jan;380(1):33-44.
45. Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Dhillon H, Swaid B, Yelangi A, Sundus S, Bachuwa G, Alkotob ML, Manson JAE. Vitamin D supplementation and cardiovascular disease risks in more than 83 000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiology 2019 Aug;4(8):765-76.
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]